Dr. Steven Theriault is a synthetic biologist with 20 years research and commercial experience in generating biological solutions for biological problems. His research on the Ebola virus contributed to the development of the Canadian Ebola vaccine that was a critical tool in curtailing the 2016 outbreak. As the Head of the Applied Research Program at the Canadian Science Centre for Human and Animal Health, Dr. Theriault worked extensively at the global level on issues related to the efficacy of microbiocides in containment laboratories and outbreak areas, genetic systems to evaluate pathogenesis in viral infectious agents, and advances in decontamination. As a professor at the University of Manitoba, he has taught numerous courses in microbiology, cell biology, immunology and virology. Through his private
laboratory, Dr. Theriault has commercialized his discoveries related to bioremediation and pathogen reduction processes.